Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely

Savvy Updates 9/3/24: Dexcom/Stelo OTC CGM, Lilly Slashes Zepbound Prices, Personal CGMs Preferred by Patients/Staff, GluFormer AI Models Predict BG Levels, Smart Insulins & Type 1 Diabetes Grand Challenge, Best Exercise for Male/Female T1Ds, PBM Execs Facing Fines/Jail, Beta Bionics Reaches 10,000 iLet Users, Choose Cheese Wisely

Dexcom prices first over-the-counter glucose monitor by Elise Reuter for MedTechDive.com, 26 August 2024. Diabetes technology company Dexcom began selling its first over-the-counter continuous glucose monitor (CGM) on Monday. The device, called Stelo, will cost $89...
Savvy Updates 8/19/24:  Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED

Savvy Updates 8/19/24: Tandem App Battery Issues, NEW Buzud CGM in Singapore, Medicare’s 1st 10 Negotiated Drug Prices, Liver-Targeted Insulin Study, Smart Insulins, Fish Oil Supplements Good or Bad?, Diabetes Media Reviews by Chris Wilson (the Glucose Genius), Dedoc Voices Scholarship Program, Dexcom Geofencing STILL NOT FIXED

Tandem warns iPhone app still draining insulin pump batteries by Elise Reuter for MedTechDive.com, 15 August 2024. Despite a software update in March, users are still reporting that the app is rapidly depleting their insulin pump batteries, causing unexpected...
Savvy Updates 6/3/24:  Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

Savvy Updates 6/3/24: Modular Medical MODD1 Insulin Pump, JDRF is REBRANDING, Semaglutide May Change Brain Response to Sweets, TCOYD+diaTribe 2024 Diabetes Forum & Reception

The Modular Medical MODD1 insulin pump. What do we know? by Tim Street for Diabettech.com, 31 May 2024. Modular Medical recently submitted their new pump system to the FDA for approval. It’s described as: “Effortless Insulin Delivery Made Possible.”...
Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

Savvy Updates, 5/28/24: CamDiab Hybrid Closed Loop Approved, FDA Rejects Icodec, Ozempic Protects Kidneys, GLP-1 OK for Surgery, Physician Compensation Report 2024, Novo Nordisk Fires, Think Like a Pancreas: Is there a conspiracy?, Air Protein Solein, FIX Prior Authorizations

FDA approves hybrid closed-loop insulin delivery app from CamDiab by Sean Whooley for DrugDelieveryBusiness.com, 24 May 2024. CamDiab announced today that the FDA granted authorization for its CamAPS FX advanced adaptive closed-loop artificial pancreas app. CamAPS FX,...
Savvy Updates, 5/6/24:  Eversense Authorized for Pump Integration, Walmart Health Shuts Down, Lilly Scales Up GLP-1 Production, Novo Prices Drop on GLP-1s, CVS Earnings Slashed, Neotame Sweetener Damages Gut, FTC Polices FDA’s Orange Book “Improper Listings”

Savvy Updates, 5/6/24: Eversense Authorized for Pump Integration, Walmart Health Shuts Down, Lilly Scales Up GLP-1 Production, Novo Prices Drop on GLP-1s, CVS Earnings Slashed, Neotame Sweetener Damages Gut, FTC Polices FDA’s Orange Book “Improper Listings”

Fully-implantable CGM receives FDA authorization for integration with insulin pumps by Jill Rollet for Healio.com/endocrinology, 30 April 2024. The Eversense E3 CGM (Senseonics Holdings and Ascensia Diabetes Care) received authorization to be marketed as an integrated...
Savvy Updates, 4/29/24:  Cadisegliatin Regulates BG in Liver, Diabetes Driving Pal App, Female Physicians Result in Better Health Outcomes, UHC Data Breach “Substantial”, Pancreas Anatomy Image, Little Sleep Risky for T1D Teens, Vertex/TreeFrog Collab, Mounjaro/Zepbound Shortages, Ozempic in Denmark, Roasted Green Tea (houjicha)

Savvy Updates, 4/29/24: Cadisegliatin Regulates BG in Liver, Diabetes Driving Pal App, Female Physicians Result in Better Health Outcomes, UHC Data Breach “Substantial”, Pancreas Anatomy Image, Little Sleep Risky for T1D Teens, Vertex/TreeFrog Collab, Mounjaro/Zepbound Shortages, Ozempic in Denmark, Roasted Green Tea (houjicha)

Introducing Cadisegliatin, a New Drug in the Type 1 Diabetes Pipeline by Ross Wollen for DiabetesDaily.com, 26 April 2024. Cadisegliatin, an investigative therapy currently entering phase 3 trials, could be the next important drug, after insulin, indicated for Type 1...
Skip to content